February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC
Feb 18, 2025, 18:35

Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC

Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared his recent article on X:

“Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC

Just out in ESMO Cancer Treatment Reviews a comprehensive overview on current landscape, challenges and perspectives.

Grateful to work with a global amazing team, including Stephanie Saw, Lizza Hendriks, Jessica Menis, Tina Cascone, Oscar Arrieta, Jarushka Naidoo, Alfredo Addeo, Solange Peters and senior author Jordi Remon.”

Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target

Authors: Giannis Mountzios, et al.

Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC